MedCity News January 23, 2025
Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites.
Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is fashioned off of the proven FSP staffing strategy used by pharmaceutical companies and CROs, leverages specialized personnel to support clinical research sites, alleviating operational pressure, enhancing site performance, and enabling faster, more efficient clinical trials.
Clinical research site staff face persistent challenges that threaten trial timelines and outcomes. A recent study...
Today's Sponsors
Today's Sponsor